Piper Sandler & Co’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,000	Closed	-$318K	–	55
2015 Q3	$318K	Buy	+8,000	New	+$318K	0.34%	37